Jennifer Viera | executive |
Jay Luly | executive |
Paul Mellett | executive |
Tara Kieffer | executive |
Eric Joseph | analyst |
Wing Yip | analyst |
Scott Rottinghaus | executive |
Roy Buchanan | analyst |
Luke Herrmann | analyst |
Jay Olson | analyst |
Good afternoon, and welcome to Enanta Pharmaceuticals' Fiscal Second Quarter Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead.
Thank you, operator, and thanks to everyone for joining us this afternoon.